Efficacy and Safety of ASP0819 in Patients with Fibromyalgia: Results of a Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

PURPOSE: ASP0819 is a novel, non-opioid K(Ca)3.1 channel opener that reverses abnormal nerve firing of primary sensory afferent nerves. Currently available treatments for fibromyalgia provide only modest relief and are accompanied by a host of adverse side effects. PATIENTS AND METHODS: In this phas...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, Leslie M, Blauwet, Mary Beth, Tracy, Katherine, Cai, Na, Walzer, Mark, Blahunka, Paul, Marek, Gerard J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735791/
https://www.ncbi.nlm.nih.gov/pubmed/33328761
http://dx.doi.org/10.2147/JPR.S274562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735791/
https://www.ncbi.nlm.nih.gov/pubmed/33328761
http://dx.doi.org/10.2147/JPR.S274562

Ejemplares similares